• 1
    van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C 2002 Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 17: 465471.
  • 2
    Altman RD, Bloch DA, Hochberg MC, Murphy WA 2000 Prevalence of pelvic Paget's disease of bone in the United States. J Bone Miner Res 15: 461465.
  • 3
    Siris ES, Ottman R, Flaster E, Kelsey JL 1991 Familial aggregation of Paget's disease of bone. J Bone Miner Res 6: 495500.
  • 4
    Sofaer JA, Holloway SM, Emery AE 1983 A family study of Paget's disease of bone. J Epidemiol Community Health 37: 226231.
  • 5
    Laurin N, Brown JP, Morissette J, Raymond V 2002 Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70: 15821588.
  • 6
    Hocking LJ, Lucas GJA, Daroszewska A, Mangion J, Olavesen M, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, Ralston SH 2002 Domain specific mutations in Sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 11: 27352739.
  • 7
    Johnson-Pais TL, Wisdom JH, Weldon KS, Cody JD, Hansen MF, Singer FR, Leach RJ 2003 Three novel mutations in SQSTM1 identified in familial Paget's disease of bone. J Bone Miner Res 18: 17481753.
  • 8
    Hocking LJ, Lucas GJA, Daroszewska A, Cundy T, Nicholson GC, Donath J, Walsh JP, Finlayson C, Cavey JR, Ciani B, Sheppard PW, Searle MS, Layfield R, Ralston SH 2004 Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: Genotype phenotype correlation, functional analysis and structural consequences. J Bone Miner Res 19: 11221127.
  • 9
    Falchetti A, Di Stefano M, Marini F, Del Monte F, Mavilia C, Strigoli D, De Feo ML, Isaia G, Masi L, Amedei A, Cioppi F, Ghinoi V, Bongi SM, Di Fede G, Sferrazza C, Rini GB, Melchiorre D, Matucci-Cerinic M, Brandi ML 2004 Two novel mutations at exon 8 of Sequestosome 1 gene (SQSTM1) in an Italian serie of patients affected by Paget's disease of bone (PDB). J Bone Miner Res 19: 10131017.
  • 10
    Eekhoff EW, Karperien M, Houtsma D, Zwinderman AH, Dragoiescu C, Kneppers AL, Papapoulos SE 2004 Familial Paget's disease in The Netherlands: Occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum 50: 16501654.
  • 11
    Duran A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP, Moscat J, Diaz-Meco MT 2004 The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell 6: 303309.
  • 12
    Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, Van Hul W, Whyte MP, Nakatsuka K, Hovy L, Anderson DM 2000 Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 24: 4548.
  • 13
    Whyte MP, Hughes AE 2002 Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J Bone Miner Res 17: 2629.
  • 14
    Nakatsuka K, Nishizawa Y, Ralston SH 2003 Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res 18: 13811385.
  • 15
    Ciani B, Layfield R, Cavey JR, Sheppard PW, Searle MS 2003 Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. J Biol Chem 278: 3740937412.
  • 16
    Kang RS, Daniels CM, Francis SA, Shih SC, Salerno WJ, Hicke L, Radhakrishnan I 2003 Solution structure of a CUE-ubiquitin complex reveals a conserved mode of ubiquitin binding. Cell 113: 621630.
  • 17
    Koradi R, Billeter M, Wuthrich K 1996 MOLMOL: A program for display and analysis of macromolecular structures. J Mol Graph 14: 5155.
  • 18
    Vadlamudi RK, Joung I, Strominger JL, Shin J 1996 p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem 271: 2023520237.
  • 19
    Wilkinson CR, Seeger M, Hartmann-Petersen R, Stone M, Wallace M, Semple C, Gordon C 2001 Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol 3: 939943.
  • 20
    Mueller TD, Feigon J 2002 Solution structures of UBA domains reveal a conserved hydrophobic surface for protein-protein interactions. J Mol Biol 319: 12431255.
  • 21
    Layfield R, Ciani B, Ralston SH, Hocking LJ, Sheppard PW, Searle MS, Cavey JR 2004 Structural and functional studies of mutations affecting the UBA domain of SQSTM1 (p62) which cause Paget's disease of bone. Biochem Soc Trans 32: 728730.
  • 22
    Prag G, Misra S, Jones EA, Ghirlando R, Davies BA, Horazdovsky BF, Hurley JH 2003 Mechanism of ubiquitin recognition by the CUE domain of Vps9p. Cell 113: 609620.
  • 23
    Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ 2001 TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346351.
  • 24
    Layfield R, Hocking L 2004 SQSTM1 and Paget's disease of bone. Calcif Tissue Int 75: 347357.
  • 25
    Sanz L, Diaz-Meco MT, Nakano H, Moscat J 2000 The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J 19: 15761586.
  • 26
    Chen L, Shinde U, Ortolan TG, Madura K 2001 Ubiquitin-associated (UBA) domains in Rad23 bind ubiquitin and promote inhibition of multi-ubiquitin chain assembly. EMBO Rep 2: 933938.
  • 27
    Hartmann-Petersen R, Hendil KB, Gordon C 2003 Ubiquitin-binding proteins protect ubiquitin conjugates from disassembly. FEBS Lett 535: 7781.
  • 28
    Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T 2000 T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408: 600605.
  • 29
    Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE 2004 Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36: 377381.
  • 30
    Asai T, Tomita Y, Nakatsuka S, Hoshida Y, Myoui A, Yoshikawa H, Aozasa K 2002 VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res 93: 296304.
  • 31
    Layfield R, Alban A, Mayer RJ, Lowe J 2001 The ubiquitin protein catabolic disorders. Neuropathol Appl Neurobiol 27: 171179.